Provided sample report
NAD+ 500 mg
Vanguard Laboratory · V260109-17 003
Read this document note
Three separate purity rows retained; unnamed 0.68% result is not relabeled as another compound. Total purity is not the NAD+-specific purity.
- Sample
- NAD+ 500 mg
- Sample specification
- 500 mg
- Laboratory shown
- Vanguard Laboratory
- Submitting client shown
- Optimum Formulas
- Report number
- V260109-17 003
- Sample lot / batch
- Y0N3T
- Date reported
- 2026-01-29
| Test shown | Method shown | Reported result |
|---|---|---|
| Chromatographic Purity (Total) | HPLC-UV/VIS | >99.80% ± 0.18% |
| Chromatographic Purity (NAD+) | HPLC-UV/VIS | 99.32% ± 0.18% |
| Chromatographic Purity | HPLC-UV/VIS | 0.68% ± 0.18% |
| Quantity: NAD+ | HPLC-UV/VIS | 471 mg |
| Sterility | USP <71> | Pass - No Growth Detected |
Results are transcribed from this sample report. The original document takes precedence; these results are not specifications or guarantees for other samples.
The submitting client is Optimum Formulas. The connection between this sample lot and current NorthVerity inventory has not been established. Request the current lot document with your inquiry.
Related catalog entries
The links below are references based on catalog naming. Confirm the chemical form, blend composition, specification and current inventory lot separately.
Original-file fingerprint
SHA-256: 9f20d080e97bc9ef664bc3bb1afd2950c419b3505fa2c7ca6e10bfaa6c4ef77b